Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Post by Pronorvistaon Apr 18, 2023 2:12pm

Ate

En tant qu'entrepreneur et investisseur en srie, Yung a cr des entreprises rvolutionnaires grande chelle dans les domaines des logiciels d'entreprise, de l'analyse mobile et du big data ...more  
Post by TechMooseon Apr 18, 2023 1:34pm

Antibe Director to Leave Position (As CEO of MaRS)

Call me an eternal optimist, but I am wondering if Yung Wu's upcoming departure may open up a window for Antibe to step out more and drive visibility.  He's a proven operator.  Smart ...more  
Post by Duster340on Apr 17, 2023 9:33am

This could be us (down the road) Bayer to buy ATE lol

Merck said on Sunday it will buy Prometheus Biosciences for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn’s disease and building up ...more  
Comment by MrMugsyon Apr 16, 2023 3:41pm

RE:RE:ATE

I agree that the last update was a nothing-burger but it did tell us a few things. 1.  Acute across the finish line is priority #1. 2.  DILIsym is now being used to get preliminary ...more  
Comment by Harper75on Apr 15, 2023 8:39am

RE:ATE

There's nothing to talk about here.  Their latest update was without anything of substance.   Still holding.  I think there is upside but Im not accumulating anymore.  I& ...more  
Comment by MrMugsyon Apr 14, 2023 8:26pm

RE:ATE

Quietly accumulating.  I'm here !
Post by Pronorvistaon Apr 12, 2023 1:46pm

ATE

Only 13k volume today
Post by Pronorvistaon Apr 12, 2023 1:44pm

ATE

the believers are all gone ???
Comment by Inthepezon Apr 12, 2023 11:11am

RE:Good Update

nice to see dumpster on his best behaviour. Glad you finally got the help you needed. 
Post by Duster340on Apr 11, 2023 12:53pm

Good Update

lots going on with the company. chronic pain still in play for otena. progress on (IBD) next update end of june for patent application filing and a announcement on anti-inflamatory compounds that are ...more  
Comment by MrMugsyon Apr 05, 2023 8:05pm

RE:i am surprised

Ya - people are unaware and uninterested at this time. All good !  I'm not one for fanfare anyway. Financials are likely out around June 28th. That's also likely the time that we get a ...more  
Post by Duster340on Apr 05, 2023 1:12pm

i am surprised

we are not geting bid up today. we usually do on days like today. this is a safe and defensive place to park some cash. and doubly so when news could come out at anytime. maybe cause we no longer have ...more  
Comment by MrMugsyon Mar 31, 2023 10:11pm

RE:RE:Q2 - 2023 Milestones

Yes - I think we've seen delays since last Q2 w.r.t. IBD. I think it all relates to proving that there isn't an ROS issue. Watching closely for the details around IBD and why they expect ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities